Bio Rad Laboratories Inc (NYSE:BIO)
| 478.72 Delayed Data As of Mar 31 |  +6.94 / +1.47%Today’s Change | 344.63 Today|||52-Week Range 607.54 | +13.85% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $11.3B |
Company Description
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Contact Information
Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules California 94547 |
Employees
Shareholders
| Other institutional | 43.27% |
| Mutual fund holders | 37.17% |
| Individual stakeholders | 26.69% |
Top Executives
| Norman D. Schwartz | Chairman, President & Chief Executive Officer |
| Andrew J. Last | Chief Operating Officer & Executive Vice President |
| Ilan Daskal | Chief Financial Officer & Executive Vice President |
| Simon May | Executive VP & President-Life Science Group |
| Timothy S. Ernst | Secretary, Executive VP & General Counsel |
